- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06547190
Study on Treating by Eating: Role of AGEs on Mucosal Barrier and Microbiome. (STEAMM)
This is an exploratory study aimed at healthy volunteers to investigate the impact of differential cooking methods on global and gut inflammation, intestinal permeability, and the gut microbiota. The investigators hypothesize that a short dietary intervention of baking and grilling of food for 2 weeks as opposed to steaming and boiling of food for 2 weeks will result in measurable differences in blood, stool and urine samples that guide towards gut and overall health and disease. All food will be provided, together with detailed cooking instructions. Food logs including photographs will be used to check whether participants complied with the study.
The investigators aim to better understand the role of cooking methods in human health, so that this can be implemented in preventive strategies and dietary treatments for specific patient groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a pilot project aimed at healthy volunteers to investigate the impact of differential cooking methods on systemic and intestinal inflammation, permeability, and the gut microbiota, using a randomised cross-over design. The investigators hypothesize that a short dietary intervention of baking and grilling of food for 2 weeks (high-Advanced Glycation End Products (AGEs) diet) as opposed to steaming and boiling of food for 2 weeks (low-AGEs diet) will result in measurable differences in inflammatory, cardiometabolic and microbial markers in blood and stool as well as changes in intestinal permeability through their effect on dietary AGEs. All food will be provided, together with detailed cooking instructions. Food logs including photographs will be used to assess and check adherence to the intervention.
The investigators aim to better understand the role of cooking methods and thermal treatments in human health, so that this can be implemented in preventive strategies and dietary treatments for specific patient groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium
- University Hospital of Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Overall healthy
- Adhering to an omnivorous diet
- Body Mass Index (BMI) between 18.5 - 30 kg/m2
- Able to provide consent.
Exclusion Criteria:
- Participants with chronic illnesses including diabetes mellitus, cardiovascular disease, or cancer; eating disorders, irritable bowel syndrome; inflammatory bowel diseases, and previous bowel surgery (except for appendectomy).
- Current smoking
- Participants taking nonsteroidal anti-inflammatory drugs (NSAIDS), proton pump inhibitors, antacids, or laxatives one month before enrollment or antibiotics, prebiotics or probiotics six months before the start of the trial.
- Pregnancy of lactation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HL
High-to-Low AGEs diet
|
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method.
The High AGEs diet was cooked for example by baking and grilling.
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method.
The low AGEs diet was cooked for example by steaming and boiling.
|
|
Experimental: LH
Low-to-High AGEs diet
|
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method.
The High AGEs diet was cooked for example by baking and grilling.
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method.
The low AGEs diet was cooked for example by steaming and boiling.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intestinal inflammation
Time Frame: 2 weeks
|
Measurement of faecal calprotectin through stool samples (in mg/kg)
|
2 weeks
|
|
Gut microbial metabolism
Time Frame: 2 weeks
|
Measurement of short chain fatty acids including acetic acid, propionic acid and butyric acid through stool samples (in mg/100g stool)
|
2 weeks
|
|
Gut microbial composition
Time Frame: 2 weeks
|
Measurement of the composition of the gut microbiota using 16s rRNA sequencing of stool samples.
|
2 weeks
|
|
Intestinal transcellular permeability
Time Frame: 2 weeks
|
Measurement of transcellular intestinal permeability using lipopolysaccharide binding protein in blood samples
|
2 weeks
|
|
Intestinal paracellular permeability
Time Frame: 2 weeks
|
Measurement of paracellular intestinal permeability using the lacultulose mannitol test using urine samples
|
2 weeks
|
|
Systemic inflammation
Time Frame: 2 weeks
|
serum inflammation through OLINK inflammatory panel (measurement of 92 proteins in blood)
|
2 weeks
|
|
Systemic inflammation
Time Frame: 2 weeks
|
Every serum CRP in blood samples (in mg/l)
|
2 weeks
|
|
Systemic cardiometabolic health
Time Frame: 2 weeks
|
serum cardiometabolic parameters through OLINK cardiometabolic panel (measurement of 92 proteins in blood)
|
2 weeks
|
|
Systemic lipid profile
Time Frame: 2 weeks
|
Total, LDL- and HDL-cholesterol values in blood samples (in mg/dl)
|
2 weeks
|
|
Weight changes
Time Frame: 2 weeks
|
weight (in kg)
|
2 weeks
|
|
Handgrip strength changes
Time Frame: 2 weeks
|
Handgrip strength (in kg)
|
2 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: João Sabino, MD, Leuven University Hospitals
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- S65600
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.